Gilead Sciences Com (GILD) Market Value Declined While Zeke Capital Advisors Has Trimmed Position by $457,590; Micron Technology (MU) Stake Has Raised by Seminole Management

December 8, 2017 - By Vivian Park

Zeke Capital Advisors Llc decreased its stake in Gilead Sciences Inc Com (GILD) by 41.43% based on its latest 2017Q2 regulatory filing with the SEC. Zeke Capital Advisors Llc sold 6,537 shares as the company’s stock declined 8.05% while stock markets rallied. The hedge fund held 9,242 shares of the health care company at the end of 2017Q2, valued at $654,000, down from 15,779 at the end of the previous reported quarter. Zeke Capital Advisors Llc who had been investing in Gilead Sciences Inc Com for a number of months, seems to be less bullish one the $94.99B market cap company. The stock decreased 0.78% or $0.57 during the last trading session, reaching $72.72. About 6.17M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since December 8, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Michael Messner increased its stake in Micron Technology Inc (MU) by 413.02% based on its latest 2017Q2 regulatory filing with the SEC. Seminole Management bought 1.01 million shares as the company’s stock rose 19.14% with the market. The hedge fund run by Michael Messner held 1.26 million shares of the technology company at the end of 2017Q2, valued at $37.53M, up from 245,000 at the end of the previous reported quarter. Seminole Management who had been investing in Micron Technology Inc for a number of months, seems to be bullish on the $49.82B market cap company. The stock increased 3.90% or $1.62 during the last trading session, reaching $43.2. About 43.19M shares traded or 13.41% up from the average. Micron Technology, Inc. (NASDAQ:MU) has risen 176.27% since December 8, 2016 and is uptrending. It has outperformed by 159.57% the S&P500.

Investors sentiment increased to 1.08 in 2017 Q2. Its up 0.03, from 1.05 in 2017Q1. It improved, as 63 investors sold MU shares while 217 reduced holdings. 85 funds opened positions while 218 raised stakes. 832.79 million shares or 1.90% less from 848.93 million shares in 2017Q1 were reported. The California-based Grassi Invest has invested 0.08% in Micron Technology, Inc. (NASDAQ:MU). Tiedemann Wealth Mgmt Lc accumulated 16,564 shares or 0.04% of the stock. Next Grp Inc has invested 0% in Micron Technology, Inc. (NASDAQ:MU). Rafferty Asset Mngmt Ltd Liability holds 0.25% or 292,684 shares. Van Eck Assocs Corporation holds 0.12% or 727,624 shares in its portfolio. Jefferies Group Ltd Liability Co owns 23,969 shares for 0% of their portfolio. Consolidated Gp Lc has 183,909 shares for 2.93% of their portfolio. Amica Mutual holds 0.22% or 81,550 shares. Vestor Cap Ltd Com reported 0.7% of its portfolio in Micron Technology, Inc. (NASDAQ:MU). River Mercantile Asset Ltd Liability Partnership reported 115,000 shares stake. Vaughan Nelson Investment Mngmt Lp invested 0.34% of its portfolio in Micron Technology, Inc. (NASDAQ:MU). Arrowmark Colorado Holdg Limited Liability holds 0.17% or 450,772 shares. South Dakota Investment Council invested in 0.04% or 60,600 shares. Ls Advsrs Ltd Liability reported 39,551 shares. Keybank Association Oh reported 40,574 shares.

More notable recent Micron Technology, Inc. (NASDAQ:MU) news were published by: Seekingalpha.com which released: “Micron Technology’s (MU) Management Presents at NASDAQ 37th Investor …” on December 06, 2017, also Seekingalpha.com with their article: “Valuation And Pitch Of Micron Technology, Inc.” published on November 27, 2017, Seekingalpha.com published: “Micron Is A No-Brainer” on December 04, 2017. More interesting news about Micron Technology, Inc. (NASDAQ:MU) were released by: Investorplace.com and their article: “Micron Technology, Inc. Faded in November — Reload Long With Confidence” published on December 07, 2017 as well as Reuters.com‘s news article titled: “BRIEF-Micron Technology Says CEO Sanjay Mehrotra’s FY 2017 Total Compensation …” with publication date: December 07, 2017.

Among 42 analysts covering Micron Technology Inc. (NASDAQ:MU), 35 have Buy rating, 0 Sell and 7 Hold. Therefore 83% are positive. Micron Technology Inc. had 193 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Wednesday, October 5 by Goldman Sachs. The rating was maintained by Morgan Stanley with “Overweight” on Wednesday, September 27. As per Thursday, October 26, the company rating was maintained by KeyBanc Capital Markets. The stock of Micron Technology, Inc. (NASDAQ:MU) has “Hold” rating given on Wednesday, October 21 by Needham. The company was upgraded on Thursday, December 22 by Summit Redstone Partners. The firm has “Neutral” rating by Robert W. Baird given on Thursday, August 20. Mizuho maintained the shares of MU in report on Wednesday, October 5 with “Buy” rating. Cowen & Co maintained Micron Technology, Inc. (NASDAQ:MU) on Monday, September 28 with “Market Perform” rating. The company was maintained on Wednesday, August 23 by Robert W. Baird. The firm earned “Buy” rating on Monday, November 27 by Morgan Stanley.

Zeke Capital Advisors Llc, which manages about $2.12B and $517.55 million US Long portfolio, upped its stake in Facebook Inc Cl A (NASDAQ:FB) by 4,428 shares to 25,145 shares, valued at $3.80M in 2017Q2, according to the filing. It also increased its holding in Coca Cola Co Com (NYSE:KO) by 7,112 shares in the quarter, for a total of 34,541 shares, and has risen its stake in Microsoft Corp Com (NASDAQ:MSFT).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences has $137 highest and $7200 lowest target. $97.12’s average target is 33.55% above currents $72.72 stock price. Gilead Sciences had 107 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Wednesday, March 23 by Credit Suisse. Berenberg initiated Gilead Sciences, Inc. (NASDAQ:GILD) on Monday, September 12 with “Buy” rating. The firm earned “Equal-Weight” rating on Thursday, May 26 by Morgan Stanley. The firm has “Market Perform” rating given on Thursday, October 5 by Leerink Swann. RBC Capital Markets maintained it with “Outperform” rating and $95 target in Monday, October 3 report. The stock has “Hold” rating by Jefferies on Friday, October 27. Needham maintained the shares of GILD in report on Wednesday, July 29 with “Buy” rating. The rating was maintained by J.P. Morgan on Monday, July 24 with “Buy”. The company was downgraded on Tuesday, September 27 by Leerink Swann. The firm has “Hold” rating given on Wednesday, October 4 by Jefferies.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 EPS, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18 billion for 10.89 P/E if the $1.67 EPS becomes a reality. After $2.23 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: